TickerGuard
Buy Day today: Neutral (46) Mixed market breadth · no major macro event
DYAI

Dyadic International Inc

Healthcare · Biotechnology

0.3802$ +5.3% vs. previous close Closing price · As of: Oct 30, 2026

Ownership

Ownership Structure

Who owns Dyadic International Inc (DYAI)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 60.3% of the shares are freely tradable; institutional investors hold 15.0%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 15.0%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 25.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 60.3%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 0.5%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 40Mio.

Largest Shareholders

Institutions

Institutions DYAI
Name Stake (%) Shares Change (%) Date
Vanguard Capital Management, LLC 2.32 928,233 +0.0 06/30/2026
Chapin Davis Inc 2.22 888,004 +0.0 06/30/2026
Apis Capital Advisors, LLC 2.01 804,882 -36.7 06/30/2026
BB&T Corp. 0.81 326,200 +0.0 06/30/2026
Geode Capital Management, LLC 0.63 250,905 -20.0 06/30/2026
BlackRock Inc 0.49 197,749 -28.2 06/30/2026
Vanguard Fiduciary Trust Co 0.35 139,478 +0.0 06/30/2026
Marathon Capital Management LLC 0.27 110,000 +0.0 06/30/2026

Funds

Funds DYAI
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 1.46 583,627 +0.0 09/30/2026
Fidelity Extended Market Index 0.31 125,687 -0.5 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?